Pamplona, Spain

Marta Ferrer Puga

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Universidad De Navarra. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marta Ferrer Puga. Retrieved from https://idiyas.com/inventor/marta-ferrer-puga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marta Ferrer Puga: Innovator in Immune Response Technologies

Introduction

Marta Ferrer Puga is a prominent inventor based in Pamplona, Spain. She has made significant contributions to the field of immunotherapy through her innovative research and development of immune response stimulating compositions.

Latest Patents

Marta holds a patent for an "Immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether-maleic acid copolymer." This composition is designed to stimulate an immune response in subjects and includes nanoparticles that may contain allergens, antigens, or immunostimulating agents. The application of this composition is particularly valuable as an adjuvant in immunotherapy and vaccines.

Career Highlights

Throughout her career, Marta has worked with esteemed institutions such as Universidad de Navarra and Instituto Científico y Tecnológico de Navarra, S.A. Her work has focused on advancing the understanding and application of nanoparticle technology in immunology.

Collaborations

Marta has collaborated with notable colleagues, including Juan Manuel Irache Garreta and Carlos Gamazo De La Rasilla. Their combined expertise has contributed to the success of her innovative projects.

Conclusion

Marta Ferrer Puga is a trailblazer in the field of immunotherapy, with her patented technologies paving the way for advancements in vaccine development and immune response enhancement. Her work exemplifies the impact of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…